Abstract:OBJECTIVE:To understand the HBV infection rate of peripheral blood mononuclear cells (PBMCs) from fetuses of HBsAg positive mothers, associated risk factors and to explore the clinical significance of detecting HBV infected PBMCs.METHODS:Sixty eight pregnant women who were delivered at the First Hospital of Xi'an Jiaotong University, China from August 1995 to February 1997, and their newborns were studied. They were divided into two groups according to their status of HBV serological markers. The study group included 50 cases who were serum HBsAg positive and 18 cases without any HBV serum markers served as control group. All these cases had no symptoms of hepatitis, high risk premature labor, premature delivery and hypertensive disorder complicating pregnancy. Age and gestational age were matched in two groups. Blood samples (5 mL) were taken from the peripheral vein of pregnant women before delivery and from newborns within 24 h after birth, before inoculation of HBV vaccine (HBVac) and injection of hepatitis B immunoglobulin (HBIG). PBMCs were isolated. The sera and PBMCs were stored at -80 degrees C. HBV-DNA in serum and PBMCs were detected with nested polymerase chain reaction (n-PCR). Two pairs of oligonucleotide primers, the outer primer pair for first PCR and inner primer pair for second PCR, designed according to region S of HBV genome were synthesized by Shanghai Cell Biology Institute of Chinese Academy of Science.RESULTS:The detection rate of HBV-DNA in serum and PBMCs from HBsAg positive pregnant women was 60.0% (30/50) and 40.0% (20/50), respectively. The detection rate of HBV-DNA in serum and PBMCs from newborns of HBsAg positive pregnant women was 46.0% (23/50) and 30.0% (15/50), respectively. Ten newborns were HBV-DNA positive in serum only, 2 were positive in PBMCs only and 13 were positive in both serum and PBMCs. In the control group, HBV-DNA was not detected in PBMC nor in serum. The positive rate of HBV-DNA in PBMCs of newborns was significantly higher in the group of mothers who were HBV-DNA or HBeAg positive in serum (P < 0.05, P < 0.01); the positive rate was significantly higher in the group of mothers who were HBV-DNA positive in both serum and PBMC than that in the group of mothers who were serum HBV-DNA positive only (P < 0.01); and it was markedly higher in the group of mothers who were PBMC HBV-DNA positive than that in group of mothers who were HBV-DNA negative in PBMCs (P < 0.01). The positive rate of HBV-DNA in PBMCs of newborns was significantly higher in the group of newborns who were HBV-DNA positive in serum than that in the group of newborns who were HBV-DNA negative in serum (P < 0.05).CONCLUSIONS:The positive rate of HBV-DNA in PBMCs from newborns of HBsAg positive pregnant women was 30.0% (15/30). It was related to HBV viremia level and HBV-DNA status in PBMCs of mothers and newborns. Detection of HBV-DNA in PBMCs may be an important supplementary method to determine intrauterine HBV infection, and can predict the response to HBV vaccine.

Determination and Seroconversion of Hepatitis B Markers in the Newborn of Hepatitis B Virus Carrier Mothers.

Study of the influencing factors about the HBsAg negative conversion of newborns of mother and infant vertical transmission

Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

Transformation of Hepatitis B Serologic Markers in Babies Born to Hepatitis B Surface Antigen Positive Mothers

The dynamic changes in serologic HBV markers in infants born by HBsAg-carrying mothers

Dynamic Changes of HBV Markers and HBV DNA Load in Infants Born to HBsAg(+) Mothers: Can Positivity of HBsAg or HBV DNA at Birth Be an Indicator for HBV Infection of Infants?

Mother‐to‐infant Transmission of Hepatitis B Virus: A Chinese Experience

Follow-Up of Newborns with Hepatitis B Antigenemia

Virological Determinants of Spontaneous Postpartum E Antigen Seroconversion and Surface Antigen Seroclearance in Pregnant Women Infected with Hepatitis B Virus.

Results of mother-to-child transmission in hepatitis B-positive mothers who underwent amniocentesis

Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

Virologic determinants of postpartum spontaneous HBeAg and/or HBsAg seroclearance or seroconver-sion in pregnant women who are chronic hepatitis B virus carriers

[Clinical Significance of Detecting Neonatal Peripheral Blood Mononuclear Cells Infected by HBV].

[Selective Transmission of Hepatitis B Virus Variant with S Gene Mutation Between HBV-carrier Mothers and Their Infants].

Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates

A Follow-Up Study on Influence Factors of Newborn Infants with Hepatitis B Virus Intrauterine Infection

Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study

Hepatitis B Virus Surface Antigen (Hbsag)-Positive and HBsAg-negative Hepatitis B Virus Infection among Mother-Teenager Pairs 13 Years after Neonatal Hepatitis B Virus Vaccination.

Evaluation for Effects of Routine Administration of Hepatitis B Vaccine and Hepatitis B Immunoglobulin on Preventing Mother-to-Infant Transmission of HBV-infected Mothers with Negative HBeAg

Study of the clinical diagnostic criteria of intrauterine Hepatitis B Virus infection

Maternal Hepatitis B E Antigen Can Be an Indicator for Antiviral Prophylaxis of Perinatal Transmission of Hepatitis B Virus